Type(s) of Cancer
Breast
Breast
Study Phase
Phase 3
Study Completion Date
January 2014
January 2014
NCT00770809Uploaded 02-02-2024
Access via NCI by Request
PDS UID: nci-data-531
Randomized Phase III Trial of Paclitaxel +Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
Files: NCT00770809-D1
Data DictionaryNCT00770809-D1-Data-Dictionary_0.pdf
DATANCT00770809-D1-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D2
Data DictionaryNCT00770809-D2-Data-Dictionary_0.pdf
DATANCT00770809-D2-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D3
Data DictionaryNCT00770809-D3-Data-Dictionary_0.pdf
DATANCT00770809-D3-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D4
Data DictionaryNCT00770809-D4-Data-Dictionary_0.pdf
DATANCT00770809-D4-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D5
Data DictionaryNCT00770809-D5-Data-Dictionary_0.pdf
DATANCT00770809-D5-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D6
Data DictionaryNCT00770809-D6-Data-Dictionary_0.pdf
DATANCT00770809-D6-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00770809-D7
Data DictionaryNCT00770809-D7-Data-Dictionary_0.pdf
DATANCT00770809-D7-Dataset_0.csv
OTHERREADME.pdf